NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=129753&wire=1 or contact Joseph E. Levi, Esq. via email at […]

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=129770&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Venture Global, Inc. ("Venture Global, Inc.") (NYSE:VG) concerning possible violations of federal securities laws. Venture Global conducted its initial public offering of 70 million shares priced at $25.00 per share on or

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=129767&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=129761&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Manhattan Associates, Inc. ("Manhattan Associates") (NASDAQ:MANH) concerning possible violations of federal securities laws. On January 28, 2025, after the market closed, Manhattan Associates published fourth quarter fiscal 2024 results and issued disappointing

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129772&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=129766&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=129763&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=129752&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or